Business
Why the Genetic Signatures (ASX:GSS) share price is edging higher
The Genetic Signatures Ltd (ASX: GSS) share price is edging higher today. This comes after the company announced that it received CE-IVD registration for its 3base EasyScreen sexually transmitted infection (STI) Genital Pathogen Detection Kit.
CE-IVD refers to an approved CE Marking from the European Union for an in vitro diagnostic (IVD) device. This allows the product to be commercially sold within Europe.
What’s driving the Genetic Signatures share price higher
The Genetic Signatures share price is back positive territory as investors jump on the company’s latest news. Originally, the company’s shares were sliding lower on the back of overall weak market sentiment.
According to its release, Genetic Signatures advised its…
-
Noosa News23 hours agoOnly person charged over Spear Creek murders admits he lied to police
-
General10 hours agoMultiple people missing after house fire in Toolooa, Gladstone
-
General11 hours agoCopper Coast Council threatens ratepayer with legal action over ‘offensive’ comment
-
General23 hours agoSouth Sydney Rabbitohs player Tyrone Munro charged with domestic violence offences